In vitro and in vivo effects of a cyclic peptide with affinity for the ανβ3 integrin in human melanoma cells
- 1 February 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (3), 410-422
- https://doi.org/10.1016/s0959-8049(99)00279-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen.Proceedings of the National Academy of Sciences, 1994
- Anchorage dependence, integrins, and apoptosisCell, 1994
- Melanoma-associated antigensEuropean Journal Of Cancer, 1993
- The progression associated antigen MUC18Melanoma Research, 1993
- Conformation/activity studies of rationally designed potent anti‐adhesive RGD peptidesEuropean Journal of Biochemistry, 1992
- Involvement of integrin alpha V gene expression in human melanoma tumorigenicity.Journal of Clinical Investigation, 1992
- Affinity of integrins for damaged extracellular matrix: αvβ3 binds to denatured collagen type I through RGD sitesBiochemical and Biophysical Research Communications, 1992
- Improved method for measuring intracellular Ca++ with fluo‐3Cytometry, 1990
- Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the moleculeNature, 1984